1-8 of 8
Sort by
News

Pirtobrutinib Combinations Effective in Small Study

Thomas R. Collins
Published: 2024
Abstract
December Supplement 2024
View News titled, Pirtobrutinib Combinations Effective in Small Study
News

Analysis Finds CLL-IPI Performs Poorly When Predicting Survival for Patients Treated With Targeted Therapies

Lara C. Pullen, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, Analysis Finds CLL-IPI Performs Poorly When Predicting Survival for Patients Treated With Targeted Therapies
News

CAR-T Therapy Effective for Richter Transformation

Lara C. Pullen, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, CAR-T Therapy Effective for Richter Transformation
News

Venetoclax Plus Obinutuzumab a Viable Option for Newly Diagnosed CLL

Anna Azvolinsky, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, Venetoclax Plus Obinutuzumab a Viable Option for Newly Diagnosed CLL
News

MRD Helpful in Predicting Progression-Free Survival in CLL

Thomas R. Collins
Published: 2024
Abstract
December Supplement 2024
View News titled, MRD Helpful in Predicting Progression-Free Survival in CLL
News

Long-Lasting, Deep Remissions Seen in R/R CLL with Triple Combination Therapy

Anna Azvolinsky, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, Long-Lasting, Deep Remissions Seen in R/R CLL with Triple Combination Therapy
News

Where to Start: BTK Inhibitors or Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia?

Emma Yasinski
Published: 2024
Abstract
December Supplement 2024
View News titled, Where to Start: BTK Inhibitors or Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia?
News

You Make the Call: How would you treat a young patient with minimally symptomatic CLL?

Published: 2024
Abstract
December Supplement 2024
View News titled, You Make the Call: How would you treat a young patient with minimally symptomatic CLL?